{
    "organizations": [],
    "uuid": "e5847662887286d50a0d8d4ea78040992fd21a90",
    "author": "Sarah Toy",
    "url": "https://www.wsj.com/articles/gene-therapy-shows-promise-in-patients-with-a-blood-disorder-1524085227",
    "ord_in_thread": 0,
    "title": "Gene Therapy Shows Promise in Patients with a Blood Disorder",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Researchers have used an experimental gene therapy developed by biotech company bluebird bio Inc. to reduce the number of blood transfusions needed in 22 people with beta-thalassemia, an inherited blood disorder.\nThe results are another sign of the promise of gene therapy, which aims to deliver beneficial genes to patientsâ€™ cells to replace defective ones.\n\nThe... To Read the Full Story Subscribe Sign In",
    "published": "2018-04-19T01:00:00.000+03:00",
    "crawled": "2018-04-19T10:45:37.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "researcher",
        "used",
        "experimental",
        "gene",
        "therapy",
        "developed",
        "biotech",
        "company",
        "bluebird",
        "bio",
        "reduce",
        "number",
        "blood",
        "transfusion",
        "needed",
        "people",
        "inherited",
        "blood",
        "disorder",
        "result",
        "another",
        "sign",
        "promise",
        "gene",
        "therapy",
        "aim",
        "deliver",
        "beneficial",
        "gene",
        "patient",
        "cell",
        "replace",
        "defective",
        "one",
        "read",
        "full",
        "story",
        "subscribe",
        "sign"
    ]
}